首页> 外文期刊>Radiology >Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session--prospective randomized study.
【24h】

Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session--prospective randomized study.

机译:有症状的甲状腺良性结节:附加射频消融治疗疗程的疗效-前瞻性随机研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose: To prospectively evaluate the efficacy of additional radiofrequency (RF) ablation by comparing the results of one and two sessions. Materials and Methods: All patients gave written informed consent to participate in this institutional review board-approved prospective study. From September 2007 to February 2008, 30 patients with benign predominantly solid thyroid nodules causing pressure symptoms and/or cosmetic problems were randomly assigned to undergo single-session (group 1, n = 15) or two-session (group 2, n = 15) RF ablation. RF ablation was performed by using an 18-gauge internally cooled electrode with ultrasonographic guidance. Nodule volume and cosmetic and symptom scores were evaluated before ablation and at 1, 3, and 6 months after initial ablation, and quantitative comparisons of these were performed by using the Mann-Whitney and Wilcoxon signed rank tests; the Spearman rank test was used for correlation between nodule volume reduction and applied energy. Results: At 6-month follow-up, there was significant nodule volume reduction, from 13.3 mL ± 12.9 (standard deviation) to 3.8 mL ± 4.4 in group 1 (P = .001), and from 13.0 mL ± 6.8 to 3.0 mL ± 2.2 in group 2 (P = .001). Each group showed significant improvement in cosmetic (P < .0001) and symptom (P = .001) scores. However, there was no significant difference in volume reduction, cosmetic score, and symptom score between two groups (P = .078, P > .99, and P = .259, respectively). In group 1, three of four patients who had a pretreatment nodule volume larger than 20 mL underwent additional RF ablation because of unresolved clinical problems after the first session. Conclusion: Single-session RF ablation showed significant volume reduction and satisfactory clinical response in most patients. Therefore, additional RF ablation should be limited to patients with a large nodule (>20 mL) or unresolved clinical problems. ?RSNA, 2012.
机译:目的:通过比较一期和两期的结果,前瞻性评估额外射频(RF)消融的疗效。资料和方法:所有患者均签署了知情同意书,以参加该机构审查委员会批准的前瞻性研究。从2007年9月至2008年2月,将30例以压力症状和/或美容问题为主的良性甲状腺实性结节患者随机分配为单次治疗(第1组,n = 15)或两次治疗(第2组,n = 15) )射频消融。射频消融是通过在超声引导下使用18号内部冷却电极进行的。在消融之前以及初始消融后1、3和6个月评估结节体积以及美容和症状评分,并使用Mann-Whitney和Wilcoxon符号秩和检验进行定量比较。 Spearman等级检验用于结节体积减少与施加能量之间的相关性。结果:在6个月的随访中,结节体积显着减少,从第1组的13.3 mL±12.9(标准偏差)降至3.8 mL±4.4(P = .001),从13.0 mL±6.8降至3.0 mL第2组的平均值为±2.2(P = .001)。每组的化妆品(P <.0001)和症状(P = .001)得分均有显着改善。但是,两组在体积减少,美容评分和症状评分方面无显着差异(分别为P = .078,P> .99和P = .259)。在第1组中,治疗前结节体积大于20 mL的四名患者中的三名由于第一次会议后未解决的临床问题而接受了额外的射频消融。结论:单次射频消融术在大多数患者中显示出明显的容量减少和令人满意的临床反应。因此,额外的射频消融应仅限于结节较大(> 20 mL)或尚未解决的临床问题的患者。 RSNA,2012年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号